Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Peter Hamar
Deciphering Multidrug-Resistant Pseudomonas aeruginosa: Mechanistic Insights and Environmental Risks
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Local Production of Acute Phase Proteins: A Defense Reaction of Cancer Cells to Injury with Focus on Fibrinogen
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors
5. Current VEGF-D Therapies Despite its importance, there is currently no specific inhibitor of VEGF-D. Reasons include: (1) The structural similarity between VEGF-D, VEGF-C, and VEGF-A with similar receptor-binding domain (VHD); (2) The complex VEGF-D signaling through VEGFR-2, VEGFR-3, and NRP-1; (3) The multiplex proteolytic cleavage of VEGF-D by different proteases providing different isoforms with variable structures.
Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReview by Kenan Aloss and Peter Hamar * Institute of Translational Medicine, Semmelweis University, 1094 Budapest, Hungary * Author to whom correspondence should be addressed.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Peter
Contact Peter, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack